IL15 and Alzheimer disease: NK cells from patients with AD exhibit susceptibility to AICD, but IL15 superagonism with rIL15/IL15Rα–Fc complexes promotes AD resolution in an NK cell-dependent manner, indicating that NK cells limit type 2 immune responses in AD [29].